A Phase I Trial of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Locally Recurrent Prostate Carcinoma.
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Motexafin lutetium (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 15 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 05 Oct 2005 New trial record.